W
Wolfgang Weber
Researcher at University of Freiburg
Publications - 169
Citations - 10186
Wolfgang Weber is an academic researcher from University of Freiburg. The author has contributed to research in topics: Positron emission tomography & Cancer. The author has an hindex of 55, co-authored 167 publications receiving 9332 citations. Previous affiliations of Wolfgang Weber include Technische Universität München & University of Zurich.
Papers
More filters
Journal ArticleDOI
Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids
Martyn Caplin,Eric Baudin,Piero Ferolla,P.L. Filosso,Mariano García-Yuste,Eric Lim,Kjell Öberg,Giuseppe Pelosi,Aurel Perren,Roberta Elisa Rossi,Roberta Elisa Rossi,William D. Travis,Detlief Bartsch,Jaume Capdevila,Frederico Costa,Jarosław B. Ćwikła,Wouter W. de Herder,Gianfranco Delle Fave,Barbro Eriksson,Massimo Falconi,Diego Ferone,David J. Gross,Ashley B. Grossman,Tetsuhide Ito,Robert T. Jensen,Gregory Kaltsas,Fahrettin Kelestimur,Reza Kianmanesh,Ulrich Knigge,Beata Kos-Kudła,Eric P. Krenning,Emmanuel Mitry,Marianne Nicolson,Juan Manuel O'Connor,Dermot O'Toole,Ulrich Frank Pape,Marianne Pavel,John Ramage,Eric Raymond,Guido Rindi,Andrea Rockall,Philippe Ruszniewski,Ramon Salazar,Aldo Scarpa,Eva Sedlackova,Anders Sundin,Christos Toumpanakis,Marie Pierre Vullierme,Wolfgang Weber,Bertram Wiedenmann,Zeng Zheng-Pei +50 more
TL;DR: PCs are complex tumors which require a multidisciplinary approach and long-term follow-up, and may be considered as first-line systemic antiproliferative treatment in unresectable PCs, particularly of low-grade TC and AC.
Journal ArticleDOI
Orthogonalization corrections for semiempirical methods
Wolfgang Weber,Walter Thiel +1 more
TL;DR: In this article, two one-electron orthogonalization corrections are derived to improve existing semi-empirical models at the neglect of the diatomic differential overlap level.
Journal Article
Use of PET for Monitoring Cancer Therapy and for Predicting Outcome
TL;DR: This review focuses on the practical aspects of (18)F-FDG PET for treatment monitoring and on how to perform a quantitative assessment of tumor uptake in clinical studies.
Journal ArticleDOI
Positron Emission Tomography Using [18F]Galacto-RGD Identifies the Level of Integrin αvβ3 Expression in Man
Ambros J. Beer,Roland Haubner,Mario Sarbia,Michael Goebel,Stephan Luderschmidt,Anca L. Grosu,Oliver Schnell,Markus Niemeyer,Horst Kessler,Hans-Jürgen Wester,Wolfgang Weber,Markus Schwaiger +11 more
TL;DR: PET with [18F]Galacto-RGD in humans correlates with αvβ3 expression as determined by immunohistochemistry and might therefore be used as a new marker of angiogenesis and for individualized planning of therapeutic strategies with α vβ3-targeted drugs.
Journal ArticleDOI
Positron Emission Tomography As an Imaging Biomarker
TL;DR: A significant number of studies have now shown that changes in tumor glucose utilization during the first weeks of chemotherapy are significantly correlated with patient outcome, suggesting that PET may be used as a sensitive test to assess the activity of new cytotoxic agents in phase II studies.